Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Wolfgang Miesbach: Can Gene Therapy Redefine Aging and Healthy Longevity?
Wolfgang Miesbach/LinkedIn
Apr 21, 2026, 09:29

Wolfgang Miesbach: Can Gene Therapy Redefine Aging and Healthy Longevity?

Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Yan Zhang et al., published in Ageing Research Reviews:

“Gene Therapy Meets Aging Biology.

A recent review explores how genetic tools could one day modify core aging mechanisms, not just individual diseases.

  • AAV‑based delivery to add ‘protective’ genes (e.g. factors supporting mitochondria, telomeres, or stress resistance) to vulnerable organs.
  • Gene silencing/editing (CRISPR, base editors, RNA tools) to switch off toxic proteins and disease‑driving variants seen in neurodegeneration and cardiomyopathy.
  • Partial reprogramming signals that nudge cells toward a more ‘youthful’ gene‑expression state while preserving their identity.

What excites me most is the paradigm shift: these approaches aim at upstream biology that feeds many conditions at once.

If we can balance efficacy, safety, and ethics, this could redefine prevention and ‘healthy longevity‘ in clinical practice.”

Title: Gene therapy for aging: Current evidence and future directions

Authors: Yan Zhang, Lianli Gan, Shixuan Wang, Jinjin Zhang

Wolfgang Miesbach: Can Gene Therapy Redefine Aging and Healthy Longevity?

Other posts featuring Wolfgang Miesbach on Hemostasis Today.

Ageing Research Reviews Biology bleeding disorders Gene editing Gene silencing Gene therapy Health Hematology Hemostasis Hemostasis News Hemostasis Today Jinjin Zhang Lianli Gan Medicine Shixuan Wang Wolfgang Miesbach Yan Zhang
NewsFeed